VCYT - Veracyte Inc News Story
$46.91 -8.5 -15.3%
Last Trade - 04/03/21
| Market Cap | £2.26bn |
| Enterprise Value | £2.01bn |
| Revenue | £84.6m |
| Position in Universe | 1752nd / 6647 |
BRIEF-Veracyte And Yale Announce Exclusive License To Advance First Genomic Monitoring Test For Idiopathic Pulmonary Fibrosis
Thu 23rd April, 2020 1:24pm
April 23 (Reuters) - Veracyte Inc VCYT.O :
* VERACYTE AND YALE ANNOUNCE EXCLUSIVE LICENSE TO ADVANCE
FIRST
GENOMIC MONITORING TEST FOR IDIOPATHIC PULMONARY FIBROSIS
Source text for Eikon: ID:nBw3hH69ka
Further company coverage: VCYT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Veracyte Inc
See all news
